Email Communication to Shareholders Regarding Dividend Taxation Provisions
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
RPG Life Sciences has informed shareholders about the tax deduction process for the dividend recommended by the Board on April 28, 2025. The company will pay a final dividend of Rs.20 per share (250% on face value of Rs.8) plus a special dividend of Rs.4 per share (50% on face value), driven by an exceptional profit from assignment of land. Resident shareholders will face 10% TDS under Section 194 of the Income Tax Act, while non-resident shareholders will have 20% TDS (plus surcharge and cess) under Section 195/196D, unless a lower rate applies under an applicable Double Taxation Avoidance Agreement (DTAA). Individual resident shareholders whose total dividend income in FY 2025-26 is below Rs.10,000 will be exempt from TDS. Shareholders must submit required documents such as PAN, Form 15G/15H, TRC, or Form 10F to the company's RTA (MUFG Intime) by June 30, 2025 to claim exemptions or beneficial DTAA rates.
Shareholders will receive a combined Rs.24 per share dividend but net of applicable TDS; those who fail to submit the required documents by June 30, 2025 risk higher tax deduction and will need to claim refunds via their income tax return.